Innovative aiTBS therapy shortens treatment duration for bipolar disorder

FHS
July 11, 2024
5:38 pm

A potential new treatment for bipolar disorder (BP) that significantly shortens treatment time has emerged, following a randomized clinical trial using accelerated intermittent theta burst stimulation (aiTBS).

AstraZeneca agrees to acquire Icosavax for $1.1bn

Share this article Following the conclusion of the tender offer, an AstraZeneca subsidiary will be merged with Icosavax. Credit: Michael Vi / Shutterstock.com. AstraZeneca has

December 13, 2023

Heidelberg Pharma AG Announces Updated Guidance – Biotech Investments

Heidelberg Pharma AG / Key word(s): Forecast Heidelberg Pharma AG Announces Updated Guidance 01-Oct-2024 / 15:27 CET/CEST Disclosure of an inside information acc. to Article

October 2, 2024

Pharmalittle: Lilly drug shows biggest weight loss yet in mid-stage trial; Biogen shareholders elect director’s romantic partner to the board

Top of the morning to you. The middle of the week is upon us and, since you made it this far, why not forge ahead?

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.